From:  How algorithms are transforming the diagnosis of ischemic heart disease—state of the art

 Implementation challenges.

CategoryChallengesSolutionsReferences
RegulatoryFDA/CE approval pathways; validation standards; lifecycle oversight of adaptive algorithmsSoftware as a Medical Device (SaMD) frameworks; dedicated guidance; post-market performance monitoring[49, 50, 56]
EthicalAlgorithmic bias; transparency/interpretability; liability; data privacyDiverse and representative datasets; bias auditing; explainable AI; accountability mechanisms[48, 51, 56]
ClinicalWorkflow integration; physician acceptance; standardization; prospective validationTraining and protocols; vendor-agnostic standards; multi-center trials to demonstrate efficacy (e.g., PROTEUS)[3436, 40, 52]
EconomicImplementation costs, reimbursement models, and uncertain ROICost-benefit analyses; value-based payment models; phased deployment; workflow efficiency gains[36, 57]

AI: artificial intelligence; CE: Conformité Européenne; FDA: Food and Drug Administration; ROI: return on investment.